...
首页> 外文期刊>BMC Endocrine Disorders >Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin
【24h】

Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin

机译:制备单体催乳素的参考间隔,以鉴定中国患者增加总催乳素患者的Macrocro actinemia

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Macroprolactin is responsible for pseudohyperprolactinemia and is a common pitfall of the prolactin immunoassay. We aimed to determine the frequency of macroprolactinemia in Chinese hyperprolactinemic patients using monomeric prolactin discriminated by precipitation with polyethylene glycol (PEG). Post-PEG monomeric prolactin gender-specific reference intervals were established for the Elecsys immunoassay method (Roche Diagnostics) using sera from healthy female (n?=?120) and male (n?=?120) donors. The reference intervals were validated using 20 macroprolactinemic (as assessed by gel filtration chromatography (GFC)) sera samples, and presence of monomeric prolactin was discriminated by GFC. Patients with high total prolactin were then screened by PEG precipitation to analyze macroprolactin. The demographic and biochemical details of patients with true hyperprolactinemia and macroprolactinemia were compared. Reference intervals for monomeric prolactin in females and males were 3.4–18.5 and 2.7–13.1 ng/mL, respectively. Among 1140 hyperprolactinemic patients, macroprolactinemia was identified in 261 (22.9?%) patients while the other 879 (77.1?%) patients were diagnosed with true hyperprolactinemia. Menstrual disturbances were the most common clinical feature in both groups. Galactorrhea, amenorrhea, and visual disturbances occurred more frequently in true hyperprolactinemic patients (P??0.05). The prevalence of macroprolactin in Chinese patients with hyperprolactinemia was described for the first time. Monomeric prolactin concentration, along with a reference interval screening with PEG precipitation, provides a diagnostic approach for hyperprolactinemia with improved accuracy.
机译:Macroplactin负责伪肺催乳素血症,是催乳素免疫测定的常见缺陷。我们的旨在使用用聚乙二醇(PEG)沉淀的单体催乳素来确定中国高丙酮蛋白血症患者Macroplactinemia的频率。使用来自健康女性(N?= 120)和血清的Elecsys免疫测定方法(roche诊断)建立了PEG后单体催乳素的性别特异性参考间隔。使用20macroplatInmexe验证的参考间隔(如通过凝胶过滤色谱(GFC)的评估)血清样品,并通过GFC区分单体催乳素的存在。然后通过PEG沉淀筛选高总催乳素的患者分析Macroplactin。比较了真正的超催乳素血症和Macroclactinemia患者的人口统计学和生化细节。女性和雄性中单体催乳素的参考间隔分别为3.4-18.5和2.7-13.1ng / ml。在1140名高溶血性患者中,MacrocoloLamemia在261名(22.9℃)患者中鉴定,而另外879名(77.1%)患者被诊断出患有真正的高催乳素血症。月经紊乱是两组中最常见的临床特征。真正的超溶血性患者(P≤0.05)中,晶状体术后的血液腐败和视觉紊乱更频繁地发生。第一次描述了中国高催乳素血症患者Macroplactin的患病率。单体催乳素浓度,以及PEG沉淀的参考间隔筛选,为高淀粉瘤的诊断方法提供了改善的精度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号